Trial Profile
Immunogenicity and safety of an adjuvant hepatitis B vaccine (fendrix) compared to Engerix in non-responding HIV-infected patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2014
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 02 Jun 2011 New trial record